Plasma Separator DigiPla80 Apheresis Machine
- Category: >>>
- Supplier: Sichuan Nigale Biotechnology Co. Ltd.
Share on (1601081359156):
Product Overview
Description
Product Description
The DigiPla 80 plasma separator introduces an enhanced operational system, featuring an interactive touch-screen and a
sophisticated display equipped with advanced data management technology. This system aims to optimize procedures, enhancing the experience for both operators and donors.
sophisticated display equipped with advanced data management technology. This system aims to optimize procedures, enhancing the experience for both operators and donors.
Specification
Product | Plasma Separator DigiPla 80 |
Place of Origin | Sichuan, China |
Brand | Nigale |
Model Number | DigiPla 80 |
Certificate | ISO13485/CE |
Instrument Classification | Class Ill |
Alarm system | Sound-light alarm system |
Screen | 10.4 inch LCD touch screen |
Warranty | 1 Year |
Weight | 35KG |
Details Images
Certifications
Company Profile
Nigale is a leading enterprise specializing in the manufacturing of automated blood processing devices and disposable kits. Headquartered in Chengdu, the capital of Sichuan province, historically recognized as the Province of Abundance, Nigale operates its production base in Jianyang, with Beijing serving as the location for its fully-owned subsidiary. Established in 1994, Nigale concentrates on products within the field of transfusion medicine, benefiting from robust technical support from the Institute of Blood Transfusion and Hematology of the Chinese Academy of Medical Sciences, as well as the Sichuan Provincial Academy of Medical Sciences.
In August 2001, Nigale transitioned into a limited liability company and subsequently evolved into a private limited liability
company by March 2004. Today, Nigale has emerged as a national leader in the manufacturing, sales, and service of blood processing systems in China. We have secured over twenty patents, encompassing inventions, utility models, and software. All our products hold Chinese SFDA certificates, ISO13485 certifications, CMDCAS certifications, and CE marks, ensuring compliance with international standards in terms of quality, specification variety, and service.
Nigale's product range is primarily employed in blood cell separation and filtration, plasma exchange therapy, as well as
operating room and clinical therapies within hospital settings.
In August 2001, Nigale transitioned into a limited liability company and subsequently evolved into a private limited liability
company by March 2004. Today, Nigale has emerged as a national leader in the manufacturing, sales, and service of blood processing systems in China. We have secured over twenty patents, encompassing inventions, utility models, and software. All our products hold Chinese SFDA certificates, ISO13485 certifications, CMDCAS certifications, and CE marks, ensuring compliance with international standards in terms of quality, specification variety, and service.
Nigale's product range is primarily employed in blood cell separation and filtration, plasma exchange therapy, as well as
operating room and clinical therapies within hospital settings.
We Recommend
New Arrivals
New products from manufacturers at wholesale prices
